|
|
|
|
||
Mitsubishi Tanabe Partner Just looked at their pipeline as of April 30,2019 and MT5199 (Valbenazine) for TD is listed as in the P2/P3 trial stage. Given the rapid adoption of Ingrezza in the US, I would think they see it as a money maker and would want to quickly advance it. JMHO. |
return to message board, top of board |
Msg # | Subject | Author | Recs | Date Posted |
46155 | Re: Mitsubishi Tanabe Partner | goirish1776 | 0 | 5/15/2019 6:46:35 PM |